John Johnson, CEO & President at SAVIENT PHARMACEUTICALS INC (SVNT), bought 28,000 shares at $3.88 ($114K) on 2011-09-14, disclosed to the SEC on 2011-09-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.88 | 1,500 | $6K | 5.1% |
| 2 | $4.09 | 1,500 | $6K | 5.4% |
| 3 | $4.10 | 25,000 | $102K | 89.6% |
| Total | $4.09 avg | 28,000 | $114K | 100% |
| Filing → |
| XERS | SELL | 2025-12-19 | $978K | — | Filing → |
| AXGN | SELL | 2025-12-10 | $2.8M | — | Filing → |
| XERS | SELL | 2025-08-15 | $787K | — | Filing → |